Back to Search
Start Over
Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
- Source :
-
Infection and immunity [Infect Immun] 2018 Oct 25; Vol. 86 (11). Date of Electronic Publication: 2018 Oct 25 (Print Publication: 2018). - Publication Year :
- 2018
-
Abstract
- Developing an effective and safe recombinant vaccine requires microbe-specific antigens combined with an adjuvant/delivery system to strengthen protective immunity. In this study, we designed and expressed a multivalent recombinant Coccidioides polypeptide antigen (rCpa1) that consists of three previously identified antigens (i.e., Ag2/Pra, Cs-Ag, and Pmp1) and five pathogen-derived peptides with high affinity for human major histocompatibility complex class II (MHC-II) molecules. The purified rCpa1 was encapsulated into four types of yeast cell wall particles containing β-glucan, mannan, and chitin in various proportions or was mixed with an oligonucleotide (ODN) containing two methylated dinucleotide CpG motifs. This multivalent antigen encapsulated into glucan-chitin particles (GCP-rCpa1) showed significantly greater reduction of fungal burden for human HLA-DR4 transgenic mice than the other adjuvant-rCpa1 formulations tested. Among the adjuvants tested, both GCPs and β-glucan particles (GPs) were capable of stimulating a mixed Th1 and Th17 response. Mice vaccinated with GCP-rCpa1 showed higher levels of interleukin 17 (IL-17) production in T-cell recall assays and earlier lung infiltration by activated Th1 and Th17 cells than GP-rCpa1-vaccinated mice. Both C57BL/6 and HLA-DR4 transgenic mice that were vaccinated with the GCP-rCpa1 vaccine showed higher survival rates than mice that received GCPs alone. Concurrently, the GCP-rCpa1 vaccine stimulated greater infiltration of the injection sites by macrophages, which engulf and process the vaccine for antigen presentation, than the GP-rCpa1 vaccine. This is the first attempt to systematically characterize the presentation of a multivalent coccidioidomycosis vaccine encapsulated with selected adjuvants that enhance the protective cellular immune response to infection.<br /> (Copyright © 2018 American Society for Microbiology.)
- Subjects :
- Animals
Antigens, Protozoan genetics
Antigens, Protozoan immunology
Disease Models, Animal
Drug Delivery Systems
HLA-DR4 Antigen genetics
HLA-DR4 Antigen metabolism
Humans
Mice, Inbred C57BL
Mice, Transgenic
Nanoparticles administration & dosage
Oligodeoxyribonucleotides administration & dosage
Protein Binding
Protozoan Vaccines administration & dosage
Protozoan Vaccines genetics
Recombinant Fusion Proteins genetics
Recombinant Fusion Proteins immunology
Survival Analysis
Th1 Cells immunology
Vaccines, Synthetic administration & dosage
Vaccines, Synthetic genetics
Vaccines, Synthetic immunology
Adjuvants, Immunologic administration & dosage
Chitin administration & dosage
Coccidioides immunology
Coccidioidomycosis prevention & control
Glucans administration & dosage
Protozoan Vaccines immunology
Th17 Cells immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1098-5522
- Volume :
- 86
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Infection and immunity
- Publication Type :
- Academic Journal
- Accession number :
- 30104216
- Full Text :
- https://doi.org/10.1128/IAI.00070-18